{"quoteSummary":{"result":[{"defaultKeyStatistics":{"maxAge":1,"priceHint":{"raw":2,"fmt":"2","longFmt":"2"},"enterpriseValue":{"raw":17239617536,"fmt":"17.24B","longFmt":"17,239,617,536"},"forwardPE":{},"profitMargins":{"raw":0.11981,"fmt":"11.98%"},"floatShares":{"raw":21056822,"fmt":"21.06M","longFmt":"21,056,822"},"sharesOutstanding":{"raw":103147000,"fmt":"103.15M","longFmt":"103,147,000"},"sharesShort":{},"sharesShortPriorMonth":{},"sharesShortPreviousMonthDate":{},"dateShortInterest":{},"sharesPercentSharesOut":{},"heldPercentInsiders":{},"heldPercentInstitutions":{},"shortRatio":{},"shortPercentOfFloat":{},"beta":{"raw":-1.304972,"fmt":"-1.3"},"morningStarOverallRating":{},"morningStarRiskRating":{},"category":null,"bookValue":{"raw":46.848,"fmt":"46.85"},"priceToBook":{"raw":3.8091273,"fmt":"3.81"},"annualReportExpenseRatio":{},"ytdReturn":{},"beta3Year":{},"totalAssets":{},"yield":{},"fundFamily":null,"fundInceptionDate":{},"legalType":null,"threeYearAverageReturn":{},"fiveYearAverageReturn":{},"priceToSalesTrailing12Months":{},"lastFiscalYearEnd":{"raw":1490918400,"fmt":"2017-03-31"},"nextFiscalYearEnd":{"raw":1553990400,"fmt":"2019-03-31"},"mostRecentQuarter":{"raw":1514592000,"fmt":"2017-12-30"},"earningsQuarterlyGrowth":{"raw":0.241,"fmt":"24.10%"},"revenueQuarterlyGrowth":{},"netIncomeToCommon":{"raw":1097879040,"fmt":"1.1B","longFmt":"1,097,879,040"},"trailingEps":{"raw":9.994,"fmt":"9.99"},"forwardEps":{},"pegRatio":{},"lastSplitFactor":"8/5","lastSplitDate":{"raw":1222387200,"fmt":"2008-09-26"},"enterpriseToRevenue":{"raw":1.881,"fmt":"1.88"},"enterpriseToEbitda":{"raw":7.36,"fmt":"7.36"},"52WeekChange":{"raw":"Infinity","fmt":"âˆž%"},"SandP52WeekChange":{"raw":0.17201865,"fmt":"17.20%"},"lastDividendValue":{},"lastCapGain":{},"annualHoldingsTurnover":{}},"earnings":{"maxAge":86400,"earningsChart":{"quarterly":[{"date":"2Q2015","actual":{"raw":1.49,"fmt":"1.49"},"estimate":{"raw":1.19,"fmt":"1.19"}},{"date":"4Q2016","actual":{"raw":1.4,"fmt":"1.40"},"estimate":{"raw":1.81,"fmt":"1.81"}}],"currentQuarterEstimateDate":"1Q","currentQuarterEstimateYear":2017},"financialsChart":{"yearly":[{"date":2014,"revenue":{"raw":3446425000,"fmt":"3.45B","longFmt":"3,446,425,000"},"earnings":{"raw":409917000,"fmt":"409.92M","longFmt":"409,917,000"}},{"date":2015,"revenue":{"raw":4071344000,"fmt":"4.07B","longFmt":"4,071,344,000"},"earnings":{"raw":599097000,"fmt":"599.1M","longFmt":"599,097,000"}},{"date":2016,"revenue":{"raw":5468941000,"fmt":"5.47B","longFmt":"5,468,941,000"},"earnings":{"raw":824825000,"fmt":"824.83M","longFmt":"824,825,000"}},{"date":2017,"revenue":{"raw":7997409000,"fmt":"8B","longFmt":"7,997,409,000"},"earnings":{"raw":856106000,"fmt":"856.11M","longFmt":"856,106,000"}}],"quarterly":[{"date":"1Q2017","revenue":{"raw":2746447000,"fmt":"2.75B","longFmt":"2,746,447,000"},"earnings":{"raw":368705000,"fmt":"368.7M","longFmt":"368,705,000"}},{"date":"2Q2017","revenue":{"raw":2225409000,"fmt":"2.23B","longFmt":"2,225,409,000"},"earnings":{"raw":211924000,"fmt":"211.92M","longFmt":"211,924,000"}},{"date":"3Q2017","revenue":{"raw":2241770000,"fmt":"2.24B","longFmt":"2,241,770,000"},"earnings":{"raw":339877000,"fmt":"339.88M","longFmt":"339,877,000"}},{"date":"4Q2017","revenue":{"raw":1944144000,"fmt":"1.94B","longFmt":"1,944,144,000"},"earnings":{"raw":179207000,"fmt":"179.21M","longFmt":"179,207,000"}}]},"financialCurrency":"INR"},"summaryProfile":{"address1":"102, Hyde Park","address2":"Saki Vihar Road Andheri (East)","city":"Mumbai","zip":"400072","country":"India","phone":"91 22 4216 0000","fax":"91 22 2856 3930","website":"http://www.blissgvs.com","industry":"Drug Manufacturers - Major","sector":"Healthcare","longBusinessSummary":"Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including anti-haemorrhoidal, erectile dysfunction, laxative, anti-inflammatory, antimalarial, anti-emetic, anti-depressant, antimigraine, antifungal, vaginal contraceptive, anti-bacterial, anti-spasmodic, lubricant, anti-infective, haematinic, appetizer, vitamin and nutritional supplement, antacid, analgesic, anti-helmintic, anti-pyretic, analgesic, antiallergic, anti-diarrheal, antibiotic, anti-ulcer, anti-microbial, anti-septic, laryngitis, and pharyngitis products. It also provides other healthcare products, such as skin lightening lotions, moisturizing soaps, total protection soaps, medicated and complexion soaps, prickly heat powders, hand sanitizers, mosquito repellants, anti-dandruff shampoos, moisturizers, insecticides, vaginal hygiene products, nasal decongestants, and cough syrups. The company offers its products in various dosage forms comprising suppositories, pessaries, dry powder for oral suspension, liquid preparations, oral solids, sachets, parenterals, topical preparations, and lozenges. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.","companyOfficers":[],"maxAge":86400},"financialData":{"maxAge":86400,"currentPrice":{"raw":178.45,"fmt":"178.45"},"targetHighPrice":{"raw":170.0,"fmt":"170.00"},"targetLowPrice":{"raw":170.0,"fmt":"170.00"},"targetMeanPrice":{"raw":170.0,"fmt":"170.00"},"targetMedianPrice":{"raw":170.0,"fmt":"170.00"},"recommendationMean":{"raw":2.0,"fmt":"2.00"},"recommendationKey":"buy","numberOfAnalystOpinions":{"raw":1,"fmt":"1","longFmt":"1"},"totalCash":{"raw":2058318976,"fmt":"2.06B","longFmt":"2,058,318,976"},"totalCashPerShare":{"raw":24.12,"fmt":"24.12"},"ebitda":{"raw":2342482688,"fmt":"2.34B","longFmt":"2,342,482,688"},"totalDebt":{"raw":2525014016,"fmt":"2.53B","longFmt":"2,525,014,016"},"quickRatio":{},"currentRatio":{},"totalRevenue":{"raw":9163644928,"fmt":"9.16B","longFmt":"9,163,644,928"},"debtToEquity":{"raw":40.408,"fmt":"40.41"},"revenuePerShare":{"raw":82.421,"fmt":"82.42"},"returnOnAssets":{},"returnOnEquity":{},"grossProfits":{"raw":4352478000,"fmt":"4.35B","longFmt":"4,352,478,000"},"freeCashflow":{},"operatingCashflow":{},"earningsGrowth":{"raw":0.5,"fmt":"50.00%"},"revenueGrowth":{"raw":-0.144,"fmt":"-14.40%"},"grossMargins":{"raw":0.54683995,"fmt":"54.68%"},"ebitdaMargins":{"raw":0.25563,"fmt":"25.56%"},"operatingMargins":{"raw":0.22805999,"fmt":"22.81%"},"profitMargins":{"raw":0.11981,"fmt":"11.98%"},"financialCurrency":"INR"}}],"error":null}}